Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer

Phu N Tran,1 Samuel J Klempner2,3 1Division of Hematology/Oncology, University of California Irvine, Irvine, CA, 2Angeles Clinic and Research Institute, 3Cedars-Sinai Medical Center, Los Angeles, CA, USA Abstract: Patients with non-small-cell lung cancer (NSCLC) harboring activating mutations in EGF...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tran PN, Klempner SJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/257d16dc79d6480186401d46e39d1bd1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!